Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Fulcrum Therapeutics (FULC) Interest & Investment Income: 2020-2025

Historic Interest & Investment Income for Fulcrum Therapeutics (FULC) over the last 5 years, with Sep 2025 value amounting to $2.3 million.

  • Fulcrum Therapeutics' Interest & Investment Income fell 34.02% to $2.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.3 million, marking a year-over-year decrease of 9.92%. This contributed to the annual value of $12.2 million for FY2024, which is 8.68% down from last year.
  • As of Q3 2025, Fulcrum Therapeutics' Interest & Investment Income stood at $2.3 million, which was down 17.65% from $2.7 million recorded in Q2 2025.
  • In the past 5 years, Fulcrum Therapeutics' Interest & Investment Income registered a high of $3.5 million during Q2 2023, and its lowest value of $34,000 during Q2 2021.
  • Its 3-year average for Interest & Investment Income is $3.1 million, with a median of $3.1 million in 2023.
  • Per our database at Business Quant, Fulcrum Therapeutics' Interest & Investment Income tumbled by 87.21% in 2021 and then surged by 4,415.71% in 2023.
  • Quarterly analysis of 5 years shows Fulcrum Therapeutics' Interest & Investment Income stood at $75,000 in 2021, then spiked by 2,350.67% to $1.8 million in 2022, then surged by 76.06% to $3.2 million in 2023, then fell by 11.59% to $2.9 million in 2024, then plummeted by 34.02% to $2.3 million in 2025.
  • Its Interest & Investment Income stands at $2.3 million for Q3 2025, versus $2.7 million for Q2 2025 and $2.9 million for Q4 2024.